ExLibris header image
SFX Logo
Title: Using a preclinical mouse model of high-grade astrocytoma to optimize p53 restoration therapy
Source:

Proceedings of the National Academy of Sciences of the United States of America [0027-8424] Shchors, K yr:2013


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Stegh, Alexander H. "Targeting the p53 signaling pathway in cancer therapy - the promises, challenges and perils." Expert opinion on therapeutic targets 16.1 (2012): 67-83. Link to SFX for this item
2. Hardesty, Rebecca A. "Much ado about mice: Standard-setting in model organism research." Studies in history and philosophy of science. 68-69: 15-24. Link to SFX for this item
3. Goodsell, David S. "The Molecular Perspective: p53 Tumor Suppressor." Stem cells 17 (1999): 189-190. Link to Full Text for this item Link to SFX for this item
4. Louis, Yutaka N. "Association of EGFR gene amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme." Brain pathology 7.3 (1997): 871-875. Link to Full Text for this item Link to SFX for this item
5. Chen, F. "Current strategies to target p53 in cancer." Biochemical Pharmacology 80.5 (2010): 724-730. Link to SFX for this item
6. Chen, Jack i. "Clonality and evolutionary history of rhabdomyosarcoma." PLoS Genetics 11.3 (2015). Link to Full Text for this item Link to SFX for this item
7. Torrens, H.S. S. "Notes on ‘The Amateur’ in the development of British geology." Proceedings of the Geologists' Association 117.1 (2006): 1-8. Link to SFX for this item
8. Didion, John P. "Deconstructing Mus gemischus: advances in understanding ancestry, structure, and variation in the genome of the laboratory mouse." Mammalian genome 24.1-2 (2013): 1-20. Link to Full Text for this item Link to SFX for this item
9. Lee, J. "Current status of experimental therapeutics for head and neck cancer." Experimental biology and medicine 236.4 (2011): 375-389. Link to SFX for this item
10. Grimm, D. "Drugs interfering with apoptosis in breast cancer." Current pharmaceutical design 17.3 (2011): 272-283. Link to SFX for this item
11. Athar, M. "Pharmacological Activation of p53 in Cancer Cells." Current pharmaceutical design 17.6 (2011): 631-639. Link to SFX for this item
12. Ozawa, T. "PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas." Genes & development 24.19 (2010): 2205-18. Link to Full Text for this item Link to SFX for this item
13. Bell, Helen S. "Targeting the p53 family for cancer therapy: Big brother joins the fight." Cell cycle 6.16 (2007): 1995-2000. Link to SFX for this item
14. Kirla, R. "Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy." Journal of neuro-oncology 46.1 (2000): 71-80. Link to Full Text for this item Link to SFX for this item
15. Melero, R. "Electron microscopy studies on the quaternary structure of p53 reveal different binding modes for p53 tetramers in complex with DNA." Proceedings of the National Academy of Sciences of the United States of America 108.2 (2011): 557-562. Link to Full Text for this item Link to SFX for this item
16. Dey, A., A. "Updates on p53: modulation of p53 degradation as a therapeutic approach." The British journal of cancer 98.1 (2008): 4-8. Link to Full Text for this item Link to SFX for this item
17. Vousden, Karen H H. "Activation of the p53 tumor suppressor protein." Biochimica et biophysica acta 1602.1 (2002): 47-59. Link to SFX for this item
18. Fuster, José J J. "Classic and novel roles of p53: prospects for anticancer therapy." Trends in molecular medicine 13.5 (2007): 192-199. Link to SFX for this item
19. Minko, T. "Molecular targeting of drug delivery systems to cancer." Current drug targets 5.4 (2004): 389-406. Link to SFX for this item
20. Xu, G. "CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component." Journal of Neuro-Oncology 136.3 (2018): 445-452. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced